Podcasts

Episode 26 | Lung Cancer Screening and its impact on patient care in Australia

A/Prof Gavin Wright discusses Lung Cancer Screening Program and its impact on patient care in Australia. He is joined by A/Prof Emily Stone, A/Prof Nicole Rankin and Paula Nelson.

Lung Cancer Screening and its impact on patient care in Australia

Episode Summary

In the latest TOGA Podcast, A/Prof Gavin Wright discusses Lung Cancer Screening and its impact on patient care in Australia, accessibility and practicalities of the MSAC recommendation for the lung cancer screening program. He is joined by A/Prof Emily Stone, A/Prof Nicole Rankin and Paula Nelson.

Show Hosts

This episode’s host are:

  • A/Prof Gavin Wright, Director of Surgical Oncology, St Vincent’s Hospital; Early NSCLC working group CoChair, TOGA
  • Prof Emily Stone, Deputy Chair, TOGA; Respiratory Physician, Senior Staff Specialist and Head of Thoracic Medicine, Department of Thoracic Medicine and Lung Transplantation, St Vincent’s Hospital Sydney; conjoint Senior Lecturer, University of New South Wales; Chair, St Vincent’s Hospital Lung Cancer Multidisciplinary team
  • A/Prof Nicole Rankin, Unit Head, Evaluation and Implementation Science, Melbourne University
  • Paula Nelson, Thoracic Liaison Nurse, Royal Melbourne Hospital

 

Play Episode 26 | Lung Cancer Screening and its impact on patient care in Australia

More Podcasts

In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical oncology and
In this introductory episode, A/Prof Mel Moore, announces the evolution of TOGA podcasts to 'Conversations in Lung Cancer Research.'
Dr Rebecca Tay is joined by Professor Ben Solomon and A/Prof Michael Ng to discuss clinical and genetic factors affecting treatment choice for ALK-Positive NSCLC
Dr Deme Karikios is joined by Dr Lauren Brown and Dr Stephen Barnett to discuss IO in early-stage NSCLC in the Australian context.
A/Prof Rachel Wong is joined by Dr Patrick Hosking, Dr Mal Itchins, and Dr Sagun Parakh discuss the diagnostic markers when identifying LC-NEC.
We dive into the latest survival data from the ADRIATIC trial, as presented at ASCO 2024, which could change the treatment landscape for LS-SCLC. Joining